Canada Life
DNA icon

Canada Life’s Ginkgo Bioworks DNA Stock Holding History

Canada Life’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,739
Closed -$194K – 2075
2024
Q2 		$194K Buy
14,739
+3,454
+31% +$103K ﹤0.01% 1815
2024
Q1 		$525K Buy
11,285
+8,152
+260% +$422K ﹤0.01% 1675
2023
Q4 		$210K Buy
3,133
+240
+8% +$14.7K ﹤0.01% 1838
2023
Q3 		$209K Buy
2,893
+1,067
+58% +$85.3K ﹤0.01% 1848
2023
Q2 		$136K Buy
1,826
+282
+18% +$16.7K ﹤0.01% 1881
2023
Q1 		$82K Buy
1,544
+192
+14% +$12.2K ﹤0.01% 2002
2022
Q4 		$92K Buy
1,352
+587
+77% +$54K ﹤0.01% 2002
2022
Q3 		$96K Buy
765
+7
+0.9% +$834 ﹤0.01% 1993
2022
Q2 		$72K Buy
+758
New +$92.5K ﹤0.01% 1972

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Canada Life's DNA Position: Q3 2024 in Review

Canada Life sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 14,739 shares — an estimated $194K sold.

Canada Life first reported a position in DNA in Q2 2022 and held it in 9 quarters. The position peaked at $525K in Q1 2024. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Canada Life reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Canada Life sold 14,739 Ginkgo Bioworks shares in Q3 2024, an estimated $194K.
  • Canada Life first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 9 quarters.
  • Canada Life's Ginkgo Bioworks position peaked at $525K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Canada Life's 13F filing for Q3 2024, filed 13 Nov 2024.